0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sexually Transmitted Diseases (STD) Diagnostics Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-5X17466
Home | Market Reports | Health| Reproductive Health
Global Sexually Transmitted Diseases STD Diagnostics Market Research Report 2024
BUY CHAPTERS

Global Sexually Transmitted Diseases (STD) Diagnostics Market Research Report 2024

Code: QYRE-Auto-5X17466
Report
June 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sexually Transmitted Diseases (STD) Diagnostics Market

The global Sexually Transmitted Diseases (STD) Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Sexually Transmitted Diseases (STD) Diagnostics is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Sexually Transmitted Diseases (STD) Diagnostics in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Sexually Transmitted Diseases (STD) Diagnostics include F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sexually Transmitted Diseases (STD) Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sexually Transmitted Diseases (STD) Diagnostics.
The Sexually Transmitted Diseases (STD) Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sexually Transmitted Diseases (STD) Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sexually Transmitted Diseases (STD) Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sexually Transmitted Diseases (STD) Diagnostics Market Report

Report Metric Details
Report Name Sexually Transmitted Diseases (STD) Diagnostics Market
Segment by Type
  • Molecular Test
  • Serologic Test
  • Point of Care Test
  • Others
Segment by Application
  • Hospital
  • Clinic
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sexually Transmitted Diseases (STD) Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sexually Transmitted Diseases (STD) Diagnostics Market report?

Ans: The main players in the Sexually Transmitted Diseases (STD) Diagnostics Market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Hologic Inc., Creative Diagnostics, Abbott Laboratories, Quest Diagnostics, BD, QIAGEN, Cepheid, bioMerieux Inc.

What are the Application segmentation covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report?

Ans: The Applications covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report?

Ans: The Types covered in the Sexually Transmitted Diseases (STD) Diagnostics Market report are Molecular Test, Serologic Test, Point of Care Test, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Molecular Test
1.2.3 Serologic Test
1.2.4 Point of Care Test
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Perspective (2019-2030)
2.2 Global Sexually Transmitted Diseases (STD) Diagnostics Growth Trends by Region
2.2.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Sexually Transmitted Diseases (STD) Diagnostics Market Dynamics
2.3.1 Sexually Transmitted Diseases (STD) Diagnostics Industry Trends
2.3.2 Sexually Transmitted Diseases (STD) Diagnostics Market Drivers
2.3.3 Sexually Transmitted Diseases (STD) Diagnostics Market Challenges
2.3.4 Sexually Transmitted Diseases (STD) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Revenue
3.1.1 Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sexually Transmitted Diseases (STD) Diagnostics Revenue
3.4 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio
3.4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2023
3.5 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics Head office and Area Served
3.6 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Product and Application
3.7 Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Type
4.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (2025-2030)
5 Sexually Transmitted Diseases (STD) Diagnostics Breakdown Data by Application
5.1 Global Sexually Transmitted Diseases (STD) Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030)
6.2 North America Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
6.4 North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030)
7.2 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
7.4 Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030)
9.2 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F.Hoffmann-La Roche Ltd
11.1.1 F.Hoffmann-La Roche Ltd Company Details
11.1.2 F.Hoffmann-La Roche Ltd Business Overview
11.1.3 F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.1.4 F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.1.5 F.Hoffmann-La Roche Ltd Recent Development
11.2 Thermo Fisher Scientific Inc.
11.2.1 Thermo Fisher Scientific Inc. Company Details
11.2.2 Thermo Fisher Scientific Inc. Business Overview
11.2.3 Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.2.5 Thermo Fisher Scientific Inc. Recent Development
11.3 Hologic Inc.
11.3.1 Hologic Inc. Company Details
11.3.2 Hologic Inc. Business Overview
11.3.3 Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.3.4 Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.3.5 Hologic Inc. Recent Development
11.4 Creative Diagnostics
11.4.1 Creative Diagnostics Company Details
11.4.2 Creative Diagnostics Business Overview
11.4.3 Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.4.4 Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.4.5 Creative Diagnostics Recent Development
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Details
11.5.2 Abbott Laboratories Business Overview
11.5.3 Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.5.4 Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.5.5 Abbott Laboratories Recent Development
11.6 Quest Diagnostics
11.6.1 Quest Diagnostics Company Details
11.6.2 Quest Diagnostics Business Overview
11.6.3 Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.6.4 Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.6.5 Quest Diagnostics Recent Development
11.7 BD
11.7.1 BD Company Details
11.7.2 BD Business Overview
11.7.3 BD Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.7.4 BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.7.5 BD Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.8.4 QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.8.5 QIAGEN Recent Development
11.9 Cepheid
11.9.1 Cepheid Company Details
11.9.2 Cepheid Business Overview
11.9.3 Cepheid Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.9.4 Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.9.5 Cepheid Recent Development
11.10 bioMerieux Inc.
11.10.1 bioMerieux Inc. Company Details
11.10.2 bioMerieux Inc. Business Overview
11.10.3 bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Introduction
11.10.4 bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
11.10.5 bioMerieux Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Molecular Test
 Table 3. Key Players of Serologic Test
 Table 4. Key Players of Point of Care Test
 Table 5. Key Players of Others
 Table 6. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 7. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2019-2024)
 Table 10. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 11. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2025-2030)
 Table 12. Sexually Transmitted Diseases (STD) Diagnostics Market Trends
 Table 13. Sexually Transmitted Diseases (STD) Diagnostics Market Drivers
 Table 14. Sexually Transmitted Diseases (STD) Diagnostics Market Challenges
 Table 15. Sexually Transmitted Diseases (STD) Diagnostics Market Restraints
 Table 16. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue by Players (2019-2024) & (US$ Million)
 Table 17. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Players (2019-2024)
 Table 18. Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Diagnostics as of 2023)
 Table 19. Ranking of Global Top Sexually Transmitted Diseases (STD) Diagnostics Companies by Revenue (US$ Million) in 2023
 Table 20. Global 5 Largest Players Market Share by Sexually Transmitted Diseases (STD) Diagnostics Revenue (CR5 and HHI) & (2019-2024)
 Table 21. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Headquarters and Area Served
 Table 22. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Product and Application
 Table 23. Global Key Players of Sexually Transmitted Diseases (STD) Diagnostics, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Type (2019-2024) & (US$ Million)
 Table 26. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Type (2019-2024)
 Table 27. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 28. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Type (2025-2030)
 Table 29. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2019-2024) & (US$ Million)
 Table 30. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Application (2019-2024)
 Table 31. Global Sexually Transmitted Diseases (STD) Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 32. Global Sexually Transmitted Diseases (STD) Diagnostics Revenue Market Share by Application (2025-2030)
 Table 33. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 34. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 35. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 36. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 37. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 38. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 39. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 40. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2019-2024) & (US$ Million)
 Table 41. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size by Region (2025-2030) & (US$ Million)
 Table 42. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 43. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 46. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2019-2024) & (US$ Million)
 Table 47. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size by Country (2025-2030) & (US$ Million)
 Table 48. F.Hoffmann-La Roche Ltd Company Details
 Table 49. F.Hoffmann-La Roche Ltd Business Overview
 Table 50. F.Hoffmann-La Roche Ltd Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 51. F.Hoffmann-La Roche Ltd Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 52. F.Hoffmann-La Roche Ltd Recent Development
 Table 53. Thermo Fisher Scientific Inc. Company Details
 Table 54. Thermo Fisher Scientific Inc. Business Overview
 Table 55. Thermo Fisher Scientific Inc. Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 56. Thermo Fisher Scientific Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 57. Thermo Fisher Scientific Inc. Recent Development
 Table 58. Hologic Inc. Company Details
 Table 59. Hologic Inc. Business Overview
 Table 60. Hologic Inc. Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 61. Hologic Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 62. Hologic Inc. Recent Development
 Table 63. Creative Diagnostics Company Details
 Table 64. Creative Diagnostics Business Overview
 Table 65. Creative Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 66. Creative Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 67. Creative Diagnostics Recent Development
 Table 68. Abbott Laboratories Company Details
 Table 69. Abbott Laboratories Business Overview
 Table 70. Abbott Laboratories Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 71. Abbott Laboratories Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 72. Abbott Laboratories Recent Development
 Table 73. Quest Diagnostics Company Details
 Table 74. Quest Diagnostics Business Overview
 Table 75. Quest Diagnostics Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 76. Quest Diagnostics Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 77. Quest Diagnostics Recent Development
 Table 78. BD Company Details
 Table 79. BD Business Overview
 Table 80. BD Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 81. BD Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 82. BD Recent Development
 Table 83. QIAGEN Company Details
 Table 84. QIAGEN Business Overview
 Table 85. QIAGEN Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 86. QIAGEN Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 87. QIAGEN Recent Development
 Table 88. Cepheid Company Details
 Table 89. Cepheid Business Overview
 Table 90. Cepheid Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 91. Cepheid Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 92. Cepheid Recent Development
 Table 93. bioMerieux Inc. Company Details
 Table 94. bioMerieux Inc. Business Overview
 Table 95. bioMerieux Inc. Sexually Transmitted Diseases (STD) Diagnostics Product
 Table 96. bioMerieux Inc. Revenue in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024) & (US$ Million)
 Table 97. bioMerieux Inc. Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Sexually Transmitted Diseases (STD) Diagnostics Picture
 Figure 2. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Type: 2023 VS 2030
 Figure 4. Molecular Test Features
 Figure 5. Serologic Test Features
 Figure 6. Point of Care Test Features
 Figure 7. Others Features
 Figure 8. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size by Application (2024-2030) & (US$ Million)
 Figure 9. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Application: 2023 VS 2030
 Figure 10. Hospital Case Studies
 Figure 11. Clinic Case Studies
 Figure 12. Others Case Studies
 Figure 13. Sexually Transmitted Diseases (STD) Diagnostics Report Years Considered
 Figure 14. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 15. Global Sexually Transmitted Diseases (STD) Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 16. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region: 2023 VS 2030
 Figure 17. Global Sexually Transmitted Diseases (STD) Diagnostics Market Share by Players in 2023
 Figure 18. Global Top Sexually Transmitted Diseases (STD) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sexually Transmitted Diseases (STD) Diagnostics as of 2023)
 Figure 19. The Top 10 and 5 Players Market Share by Sexually Transmitted Diseases (STD) Diagnostics Revenue in 2023
 Figure 20. North America Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. North America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2019-2030)
 Figure 22. United States Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 23. Canada Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. Europe Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2019-2030)
 Figure 26. Germany Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. France Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. U.K. Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Italy Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Russia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 31. Nordic Countries Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. Asia-Pacific Sexually Transmitted Diseases (STD) Diagnostics Market Share by Region (2019-2030)
 Figure 34. China Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. Japan Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. South Korea Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Southeast Asia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. India Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 39. Australia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Latin America Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2019-2030)
 Figure 42. Mexico Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 43. Brazil Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. Middle East & Africa Sexually Transmitted Diseases (STD) Diagnostics Market Share by Country (2019-2030)
 Figure 46. Turkey Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 47. Saudi Arabia Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 48. UAE Sexually Transmitted Diseases (STD) Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 49. F.Hoffmann-La Roche Ltd Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 50. Thermo Fisher Scientific Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 51. Hologic Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 52. Creative Diagnostics Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 53. Abbott Laboratories Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 54. Quest Diagnostics Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 55. BD Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 56. QIAGEN Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 57. Cepheid Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 58. bioMerieux Inc. Revenue Growth Rate in Sexually Transmitted Diseases (STD) Diagnostics Business (2019-2024)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS